Botulinum Toxin A (Dysport®)In Dystonias and Focal Spasticity

被引：0
|
作者：
Susan J. Keam
Victoria J. Muir
Emma D. Deeks
机构：
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源：
Drugs | 2011年 / 71卷
关键词：
Cerebral Palsy; Dystonia; Botulinum Toxin; Cervical Dystonia; Blepharospasm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Dysport®, a formulation of botulinum toxin A, blocks acetylcholine release at neuromuscular junctions causing denervation and temporary muscle paralysis. It is used to treat several medical conditions, including dystonias and focal spasticity.
引用
收藏
页码：1043 / 1058
页数：15
相关论文
共 50 条
  • [1] Botulinum Toxin A (Dysport®) In Dystonias and Focal Spasticity
    Keam, Susan J.
    Muir, Victoria J.
    Decks, Emma D.
    DRUGS, 2011, 71 (08) : 1043 - 1058
  • [2] Focal dystonias and their treatment with dysport (botulinum toxin type A)
    Orlova, O. R.
    Timerbaeva, S. L.
    Khat'kova, S. E.
    Kotlyarov, V. V.
    Korenko, L. A.
    Zalyalova, Z. A.
    Fal'kovsky, I. V.
    Shperling, L. P.
    Antipova, L. N.
    Antipenko, E. A.
    Mingazova, L. R.
    Soikher, M. I.
    Krasavina, D. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2012, 112 (05) : 81 - 89
  • [3] Botulinum Toxin Effects on Sensorimotor Integration in Focal Dystonias
    De Bartolo, Maria Ilenia
    Manzo, Nicoletta
    Ferrazzano, Gina
    Baione, Viola
    Belvisi, Daniele
    Fabbrini, Giovanni
    Berardelli, Alfredo
    Conte, Antonella
    TOXINS, 2020, 12 (05)
  • [4] Efficacy of botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: experience of the Botulinum Toxin Outpatients Department
    Tomic, Aleksandra
    Vujovic, Balsa
    Svetel, Marina
    Miskovic, Natasa Dragasevic
    Petrovic, Igor
    Pekmezovic, Tatjana
    Kostic, Vladimir S.
    VOJNOSANITETSKI PREGLED, 2015, 72 (12) : 1069 - 1073
  • [5] Costs of Treating Dystonias and Hemifacial Spasm with Botulinum Toxin A
    Richard C. Dodel
    Annette Kirchner
    Rudolf Koehne-Volland
    Gabriella Künig
    Andres Ceballos-Baumann
    Markus Naumann
    Allison Brashear
    Hans P. Richter
    Thomas D. Szucs
    Wolfgang H. Oertel
    PharmacoEconomics, 1997, 12 : 695 - 706
  • [6] A study of the effectiveness of botulinum toxin type A (Dysport) in the management of muscle spasticity
    Watanabe, Y
    Bakheit, AMO
    McLellan, DL
    DISABILITY AND REHABILITATION, 1998, 20 (02) : 62 - 65
  • [7] Botulinum toxins in the treatment of primary focal dystonias
    Truong, Daniel
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 316 (1-2) : 9 - 14
  • [8] Botulinum toxin treatment of dystonias - State of the art
    Benecke, R
    Dressler, D
    NERVENHEILKUNDE, 2006, 25 (07) : 527 - +
  • [9] Treatment of focal dystonias with botulinum neurotoxin
    Hallett, Mark
    Benecke, Reiner
    Blitzer, Andrew
    Comella, Cynthia L.
    TOXICON, 2009, 54 (05) : 628 - 633
  • [10] Perspectives of botulinum toxin treatment of dystonias
    Dressler, D
    Benecke, R
    KLINISCHE NEUROPHYSIOLOGIE, 2001, 32 (04) : 213 - 217
12345